The National Agency for Food and Drug Administration and Control (NAFDAC), has emphasised its commitment to due process in the importation of Rifampicin, an anti-leprosy drug, into Nigeria.
NAFDAC’s Director-General, Mojisola Adeyeye, explained the agency’s position on the matter in a statement issued on Monday.
Mrs Adeyeye, a professor was responding to a BBC report titled “Vital leprosy drugs due in Nigeria after year delay”.
The report had suggested that NAFDAC had either…
Read the full article here
